PortfoliosLab logoPortfoliosLab logo
CLOV vs. STNE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLOV vs. STNE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and StoneCo Ltd. (STNE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLOV achieves a 101.28% return, which is significantly higher than STNE's -7.84% return.


CLOV

1D
-3.47%
1M
33.24%
YTD
101.28%
6M
75.19%
1Y
61.43%
3Y*
66.22%
5Y*
-20.64%
10Y*

STNE

1D
0.09%
1M
16.20%
YTD
-7.84%
6M
-12.12%
1Y
-2.22%
3Y*
0.22%
5Y*
-26.45%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CLOV vs. STNE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
CLOV
Clover Health Investments, Corp.
101.28%-25.40%230.85%2.43%-75.01%-77.82%66.53%
STNE
StoneCo Ltd.
-7.84%85.57%-55.80%91.00%-44.01%-79.91%142.68%

Correlation

The correlation between CLOV and STNE is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.24

Correlation (3Y)
Calculated over the trailing 3-year period

0.25

Correlation (5Y)
Calculated over the trailing 5-year period

0.36

Correlation (All Time)
Calculated using the full available price history since Jun 12, 2020

0.35

The correlation between CLOV and STNE shifts across timeframes, from 0.24 (1 year) to 0.36 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CLOV:

$2.47B

STNE:

$2.85B

EPS

CLOV:

-$0.11

STNE:

R$12.96

PS Ratio

CLOV:

1.10

STNE:

1.32

PB Ratio

CLOV:

7.28

STNE:

1.20

Total Revenue (TTM)

CLOV:

$2.21B

STNE:

R$11.69B

Gross Profit (TTM)

CLOV:

$939.14M

STNE:

R$8.11B

EBITDA (TTM)

CLOV:

-$55.21M

STNE:

R$3.75B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLOV vs. STNE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV
CLOV Risk / Return Rank: 6868
Overall Rank
CLOV Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
CLOV Sortino Ratio Rank: 7070
Sortino Ratio Rank
CLOV Omega Ratio Rank: 7070
Omega Ratio Rank
CLOV Calmar Ratio Rank: 6666
Calmar Ratio Rank
CLOV Martin Ratio Rank: 6363
Martin Ratio Rank

STNE
STNE Risk / Return Rank: 4040
Overall Rank
STNE Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
STNE Sortino Ratio Rank: 3939
Sortino Ratio Rank
STNE Omega Ratio Rank: 3939
Omega Ratio Rank
STNE Calmar Ratio Rank: 4141
Calmar Ratio Rank
STNE Martin Ratio Rank: 4141
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLOV vs. STNE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and StoneCo Ltd. (STNE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CLOVSTNEDifference
Sharpe ratioReturn per unit of total volatility

+0.91

Sortino ratioReturn per unit of downside risk

+1.33

Omega ratioGain probability vs. loss probability

1.20

1.04

+0.17

Calmar ratioReturn relative to maximum drawdown

1.11

-0.06

+1.17

Martin ratioReturn relative to average drawdown

2.02

-0.11

+2.13

CLOV vs. STNE - Sharpe Ratio Comparison

The current CLOV Sharpe Ratio is 0.87, which is higher than the STNE Sharpe Ratio of -0.04. The chart below compares the historical Sharpe Ratios of CLOV and STNE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CLOV vs. STNE - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.19%, which is greater than STNE's maximum drawdown of -92.31%. Use the drawdown chart below to compare losses from any high point for CLOV and STNE.


Loading charts...

Drawdown Indicators


CLOVSTNEDifference

Max Drawdown

Largest peak-to-trough decline

-97.19%

-92.31%

-4.88%

Max Drawdown (1Y)

Largest decline over 1 year

-55.50%

-40.22%

-15.28%

Max Drawdown (3Y)

Largest decline over 3 years

-64.73%

-57.64%

-7.09%

Max Drawdown (5Y)

Largest decline over 5 years

-95.76%

-89.72%

-6.04%

Current Drawdown

Current decline from peak

-78.65%

-85.51%

+6.86%

Average Drawdown

Average peak-to-trough decline

-76.59%

-61.22%

-15.37%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.46%

20.10%

+10.36%

Volatility

CLOV vs. STNE - Volatility Comparison

Clover Health Investments, Corp. (CLOV) has a higher volatility of 26.03% compared to StoneCo Ltd. (STNE) at 14.09%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than STNE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLOVSTNEDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.03%

14.09%

+11.94%

Volatility (6M)

Calculated over the trailing 6-month period

43.15%

39.14%

+4.01%

Volatility (1Y)

Calculated over the trailing 1-year period

71.33%

51.30%

+20.03%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

77.38%

64.94%

+12.44%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

85.80%

67.40%

+18.40%

Dividends

CLOV vs. STNE - Dividend Comparison

CLOV has not paid dividends to shareholders, while STNE's dividend yield for the trailing twelve months is around 22.47%.


PositionTTM
CLOV
Clover Health Investments, Corp.
0.00%
STNE
StoneCo Ltd.
22.47%

Financials

CLOV vs. STNE - Financials Comparison

This section allows you to compare key financial metrics between Clover Health Investments, Corp. and StoneCo Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B20222023202420252026
749.19M
719.52M
(CLOV) Total Revenue
(STNE) Total Revenue
Please note, different currencies. CLOV values in USD, STNE values in BRL

Frequently Asked Questions


CLOV and STNE have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLOV has higher volatility (26.03%) compared to STNE (14.09%). In terms of maximum drawdown, CLOV dropped -97.19% vs STNE's -92.31%.

CLOV currently has the higher Sharpe Ratio (0.87 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLOV and STNE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer